Real-time Estimate
Cboe BZX
20:15:52 03/05/2024 BST
|
5-day change
|
1st Jan Change
|
18.48
USD
|
+0.41%
|
|
+1.31%
|
-19.67%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,755
|
2,596
|
2,719
|
2,184
|
-
|
-
|
Enterprise Value (EV)
1 |
2,467
|
2,248
|
2,330
|
1,726
|
1,636
|
1,532
|
P/E ratio
|
-14.1
x
|
-284
x
|
121
x
|
78.2
x
|
56.4
x
|
45.6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.85
x
|
1.91
x
|
1.64
x
|
1.33
x
|
1.17
x
|
1.02
x
|
EV / Revenue
|
2.55
x
|
1.66
x
|
1.41
x
|
1.05
x
|
0.87
x
|
0.71
x
|
EV / EBITDA
|
59.6
x
|
36.9
x
|
32.3
x
|
19.8
x
|
15.3
x
|
11.7
x
|
EV / FCF
|
45.3
x
|
47.7
x
|
28.9
x
|
22.8
x
|
17.8
x
|
13
x
|
FCF Yield
|
2.21%
|
2.1%
|
3.46%
|
4.38%
|
5.61%
|
7.69%
|
Price to Book
|
6.44
x
|
5.22
x
|
5.11
x
|
3.44
x
|
3.07
x
|
2.69
x
|
Nbr of stocks (in thousands)
|
106,499
|
114,299
|
118,064
|
118,656
|
-
|
-
|
Reference price
2 |
25.87
|
22.71
|
23.03
|
18.41
|
18.41
|
18.41
|
Announcement Date
|
22/03/22
|
28/02/23
|
27/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
817.1
|
966.2
|
1,357
|
1,658
|
1,644
|
1,873
|
2,148
|
EBITDA
1 |
-
|
41.38
|
60.85
|
72.23
|
87.4
|
106.7
|
131
|
EBIT
1 |
-
|
-217.4
|
-19.12
|
20.65
|
30.23
|
47.79
|
66.4
|
Operating Margin
|
-
|
-22.5%
|
-1.41%
|
1.25%
|
1.84%
|
2.55%
|
3.09%
|
Earnings before Tax (EBT)
1 |
-
|
-218.5
|
-18.58
|
29.02
|
39.06
|
55.92
|
71.55
|
Net income
1 |
-
|
-188.2
|
-8.585
|
23.08
|
29.78
|
42.31
|
55.29
|
Net margin
|
-
|
-19.48%
|
-0.63%
|
1.39%
|
1.81%
|
2.26%
|
2.57%
|
EPS
2 |
0.3300
|
-1.830
|
-0.0800
|
0.1900
|
0.2355
|
0.3266
|
0.4037
|
Free Cash Flow
1 |
-
|
54.51
|
47.09
|
80.67
|
75.66
|
91.7
|
117.8
|
FCF margin
|
-
|
5.64%
|
3.47%
|
4.87%
|
4.6%
|
4.9%
|
5.48%
|
FCF Conversion (EBITDA)
|
-
|
131.74%
|
77.39%
|
111.69%
|
86.56%
|
85.96%
|
89.86%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
349.55%
|
254.05%
|
216.71%
|
212.96%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
17/03/21
|
22/03/22
|
28/02/23
|
27/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
251.5
|
275.3
|
313.8
|
335.5
|
342.9
|
364.4
|
386.3
|
413.4
|
417.3
|
440.8
|
394.8
|
407.1
|
413
|
429.3
|
455.7
|
EBITDA
1 |
13.87
|
7.528
|
14.8
|
15.53
|
15.65
|
14.26
|
16.86
|
19.31
|
18.77
|
17.28
|
19.77
|
21.98
|
23.22
|
22.36
|
23.59
|
EBIT
1 |
-12.81
|
-19.35
|
-11.55
|
-5.25
|
-4.574
|
2.249
|
6.714
|
6.979
|
5.536
|
1.42
|
5.641
|
7.757
|
8.976
|
8.167
|
10.22
|
Operating Margin
|
-5.09%
|
-7.03%
|
-3.68%
|
-1.56%
|
-1.33%
|
0.62%
|
1.74%
|
1.69%
|
1.33%
|
0.32%
|
1.43%
|
1.91%
|
2.17%
|
1.9%
|
2.24%
|
Earnings before Tax (EBT)
1 |
-13.1
|
-19.53
|
-11.78
|
-5.913
|
-4.289
|
3.401
|
8.527
|
7.796
|
8.43
|
4.268
|
7.482
|
9.781
|
11
|
10.55
|
11.82
|
Net income
1 |
-9.115
|
-11.98
|
-17.51
|
-10.48
|
1.624
|
17.78
|
7.324
|
7.274
|
5.643
|
2.838
|
6.063
|
7.7
|
8.316
|
7.752
|
8.838
|
Net margin
|
-3.62%
|
-4.35%
|
-5.58%
|
-3.12%
|
0.47%
|
4.88%
|
1.9%
|
1.76%
|
1.35%
|
0.64%
|
1.54%
|
1.89%
|
2.01%
|
1.81%
|
1.94%
|
EPS
2 |
-0.0900
|
-0.1100
|
-0.1600
|
-0.1000
|
0.0100
|
0.1400
|
0.0600
|
0.0600
|
0.0500
|
0.0200
|
0.0473
|
0.0602
|
0.0659
|
0.0622
|
0.0695
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
08/11/21
|
22/03/22
|
12/05/22
|
11/08/22
|
10/11/22
|
28/02/23
|
04/05/23
|
03/08/23
|
03/11/23
|
27/02/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
288
|
348
|
390
|
458
|
549
|
653
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
54.5
|
47.1
|
80.7
|
75.7
|
91.7
|
118
|
ROE (net income / shareholders' equity)
|
-
|
-65.6%
|
-1.85%
|
4.35%
|
4.84%
|
5.34%
|
6.02%
|
ROA (Net income/ Total Assets)
|
-
|
-37.1%
|
-1.16%
|
2.57%
|
2.82%
|
3.48%
|
-
|
Assets
1 |
-
|
507.7
|
739.6
|
896.4
|
1,057
|
1,217
|
-
|
Book Value Per Share
2 |
-
|
4.020
|
4.350
|
4.500
|
5.350
|
6.000
|
6.850
|
Cash Flow per Share
2 |
-
|
0.5300
|
0.4300
|
0.6500
|
0.6000
|
0.6300
|
-
|
Capex
1 |
-
|
0.55
|
0.1
|
0.11
|
0.78
|
0.91
|
1.31
|
Capex / Sales
|
-
|
0.06%
|
0.01%
|
0.01%
|
0.05%
|
0.05%
|
0.06%
|
Announcement Date
|
17/03/21
|
22/03/22
|
28/02/23
|
27/02/24
|
-
|
-
|
-
|
Last Close Price
18.41
USD Average target price
27.06
USD Spread / Average Target +46.96% Consensus |
1st Jan change
|
Capi.
|
---|
| -19.67% | 2.18B | | +14.32% | 81.68B | | -28.81% | 69.23B | | +9.72% | 29.08B | | -11.52% | 16.88B | | -0.43% | 16.85B | | -1.10% | 15.15B | | +3.42% | 12.62B | | +29.56% | 12.47B | | -30.70% | 11.89B |
Other Healthcare Facilities & Services
|